Results of peripheral vasculopathy, like Raynaud’s phenomenon, were being observed in postmarketing reviews and at the therapeutic dosages of CNS stimulants in all age teams through the program of procedure. Indications and symptoms frequently improved after dosage reduction or discontinuation